197 related articles for article (PubMed ID: 34289372)
1. Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer.
Dieter SM; Siegl C; Codó PL; Huerta M; Ostermann-Parucha AL; Schulz E; Zowada MK; Martin S; Laaber K; Nowrouzi A; Blatter M; Kreth S; Westermann F; Benner A; Uhrig U; Putzker K; Lewis J; Haegebarth A; Mumberg D; Holton SJ; Weiske J; Toepper LM; Scheib U; Siemeister G; Ball CR; Kuster B; Stoehr G; Hahne H; Johannes S; Lange M; Herbst F; Glimm H
Cell Rep; 2021 Jul; 36(3):109394. PubMed ID: 34289372
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation.
Lv L; Chen P; Cao L; Li Y; Zeng Z; Cui Y; Wu Q; Li J; Wang JH; Dong MQ; Qi X; Han T
Elife; 2020 Aug; 9():. PubMed ID: 32804079
[TBL] [Abstract][Full Text] [Related]
3. The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K.
Słabicki M; Kozicka Z; Petzold G; Li YD; Manojkumar M; Bunker RD; Donovan KA; Sievers QL; Koeppel J; Suchyta D; Sperling AS; Fink EC; Gasser JA; Wang LR; Corsello SM; Sellar RS; Jan M; Gillingham D; Scholl C; Fröhling S; Golub TR; Fischer ES; Thomä NH; Ebert BL
Nature; 2020 Sep; 585(7824):293-297. PubMed ID: 32494016
[TBL] [Abstract][Full Text] [Related]
4. Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor.
Niu T; Li K; Jiang L; Zhou Z; Hong J; Chen X; Dong X; He Q; Cao J; Yang B; Zhu CL
Eur J Med Chem; 2022 Jan; 228():114012. PubMed ID: 34864331
[TBL] [Abstract][Full Text] [Related]
5. Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation.
Neitzel C; Seiwert N; Göder A; Diehl E; Weber C; Nagel G; Stroh S; Rasenberger B; Christmann M; Fahrer J
Cells; 2019 Jul; 8(8):. PubMed ID: 31366086
[TBL] [Abstract][Full Text] [Related]
6. Rational discovery of molecular glue degraders via scalable chemical profiling.
Mayor-Ruiz C; Bauer S; Brand M; Kozicka Z; Siklos M; Imrichova H; Kaltheuner IH; Hahn E; Seiler K; Koren A; Petzold G; Fellner M; Bock C; Müller AC; Zuber J; Geyer M; Thomä NH; Kubicek S; Winter GE
Nat Chem Biol; 2020 Nov; 16(11):1199-1207. PubMed ID: 32747809
[TBL] [Abstract][Full Text] [Related]
7. CDK12 orchestrates super-enhancer-associated CCDC137 transcription to direct hepatic metastasis in colorectal cancer.
Dai W; Wu J; Peng X; Hou W; Huang H; Cheng Q; Liu Z; Luyten W; Schoofs L; Zhou J; Liu S
Clin Transl Med; 2022 Oct; 12(10):e1087. PubMed ID: 36254394
[TBL] [Abstract][Full Text] [Related]
8. Design principles for cyclin K molecular glue degraders.
Kozicka Z; Suchyta DJ; Focht V; Kempf G; Petzold G; Jentzsch M; Zou C; Di Genua C; Donovan KA; Coomar S; Cigler M; Mayor-Ruiz C; Schmid-Burgk JL; Häussinger D; Winter GE; Fischer ES; Słabicki M; Gillingham D; Ebert BL; Thomä NH
Nat Chem Biol; 2024 Jan; 20(1):93-102. PubMed ID: 37679459
[TBL] [Abstract][Full Text] [Related]
9. The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes.
Blazek D; Kohoutek J; Bartholomeeusen K; Johansen E; Hulinkova P; Luo Z; Cimermancic P; Ule J; Peterlin BM
Genes Dev; 2011 Oct; 25(20):2158-72. PubMed ID: 22012619
[TBL] [Abstract][Full Text] [Related]
10. CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability.
Choi SH; Martinez TF; Kim S; Donaldson C; Shokhirev MN; Saghatelian A; Jones KA
Genes Dev; 2019 Apr; 33(7-8):418-435. PubMed ID: 30819820
[TBL] [Abstract][Full Text] [Related]
11. Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells.
Anchoori RK; Khan SR; Sueblinvong T; Felthauser A; Iizuka Y; Gavioli R; Destro F; Isaksson Vogel R; Peng S; Roden RB; Bazzaro M
PLoS One; 2011; 6(8):e23888. PubMed ID: 21909374
[TBL] [Abstract][Full Text] [Related]
12. CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer.
Lei H; Wang Z; Jiang D; Liu F; Liu M; Lei X; Yang Y; He B; Yan M; Huang H; Liu Q; Pang J
Cell Death Dis; 2021 Jul; 12(8):740. PubMed ID: 34315855
[TBL] [Abstract][Full Text] [Related]
13. YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer.
Chen C; Zhu D; Zhang H; Han C; Xue G; Zhu T; Luo J; Kong L
Cell Death Dis; 2018 May; 9(6):591. PubMed ID: 29789528
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligase.
Yan W; Jung YS; Zhang Y; Chen X
PLoS One; 2014; 9(8):e103497. PubMed ID: 25116336
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Nef promotes ubiquitination and proteasomal degradation of p53 tumor suppressor protein by using E6AP.
Ali A; Farooqui SR; Rai J; Singh J; Kumar V; Mishra R; Banerjea AC
Biochem Biophys Res Commun; 2020 Sep; 529(4):1038-1044. PubMed ID: 32819562
[TBL] [Abstract][Full Text] [Related]
16. Advances in Protein Degradation.
Castaldi MP; Fisher SL
SLAS Discov; 2021 Apr; 26(4):471-473. PubMed ID: 33780295
[No Abstract] [Full Text] [Related]
17. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.
Li K; Wang F; Yang ZN; Zhang TT; Yuan YF; Zhao CX; Yeerjiang Z; Cui B; Hua F; Lv XX; Zhang XW; Yu JJ; Liu SS; Yu JM; Shang S; Xiao Y; Hu ZW
Nat Commun; 2020 Dec; 11(1):6316. PubMed ID: 33298911
[TBL] [Abstract][Full Text] [Related]
18. The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression.
Zou T; Lin Z
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072267
[TBL] [Abstract][Full Text] [Related]
19. N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2.
Yang X; Zhu F; Yu C; Lu J; Zhang L; Lv Y; Sun J; Zheng M
Oncotarget; 2017 Jul; 8(29):47709-47724. PubMed ID: 28537875
[TBL] [Abstract][Full Text] [Related]
20. A High-Throughput Cell-Based Screen Identified a 2-[(E)-2-Phenylvinyl]-8-Quinolinol Core Structure That Activates p53.
Bechill J; Zhong R; Zhang C; Solomaha E; Spiotto MT
PLoS One; 2016; 11(4):e0154125. PubMed ID: 27124407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
